6Johnston TH, Brotchie JM. Drugs in development for Parkinson's disease. Curr Opin Investig,2006,7( 1 ) :25-32.
7Rased O, Brooks D J, Melamed E, et al. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations: a randomised, double-blind, parallel-group trial. Lancet, 2005,365 ( 9463 ) : 947 -954.
8Guay DR. Rasagiline(TVP-1012) :a new selective monoamine oxldaze inhibitor for Parkinson's disease. Geriatric Am J Geriatr Pharmacother,2006,4 (4) :330-346.
9Agid Y. Entacapone to tolcapone switch : multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease. Mov Disord,2006,22( 1 ) :14-19.
10Clifford WS. Therapeutic role of coenzyme Q10 in Parkinson's disease. Pharmacol Ther,2005,1 ( 107 ) : 120-130.
